Posts tagged “GSK”
Biotech Center Names VP for Business, Technology Development
NCEITA Sets Tech Briefing in Raleigh on Tuesday
One Month Wonder: Experts Say Rush of Venture Deals Won't Last
A flurry of deals across the Southeast in August added more than $150 million to the coffers of regional startups - almost twice the monthly average through July. But several VCs call it a coincidence and predict more slow times ahead.
Digiton Exec To Address B2T Conference
Execs To Watch: The 17 Men, Women on Cutting Edge of Triangle Tech
<b>High-Tech 100:</b> Local Tech Wire, in partnership with Raleigh Metro Magazine, produced the magazine's third annual 'High-Tech 100' issue. Here are the men and women to watch in Triangle Tech.
TRG Wins Contract With International Drug Firm
Life Sciences Law Firm Focuses on Helping Biotech, Pharma Startups
Sheila Mikhail left larger office to launch new niche venture. <b>Other news:</b>Another startup, Wilder Communications, hopes to give media savy to startups.
Wake Forest Spinoff Snags First Funding, Looks For More
Kucera Pharmaceuticals, which uses a technology that improves the effectiveness of drugs to fight viral diseases and cancer, has obtained $1.9 million from Academy Funds and angel investors and is talking to other venture firms.
Nobex Grabs $22.5M in Venture Cash to Build Drug Pipeline
After turning over most of the work on its oral insulin to GSK, Durham drug firm plans to use its funding, including another $12.5 million raised last fall, to take other pill versions of protein-based drugs through clinical trials.
Report: Merix Bioscience CEO Resigns, Clinical Trials Delayed
Newspaper reports that the Durham-based biotech company is searching for a new president and CEO following Mark Weedon's sudden departure and that it is behind schedule in tests of its cancer treatment.
SciQuest Losses Narrow in 2Q
Notre Dame Picks SciQuest
Chapel Hill's Buoy5 Stays Well Afloat with New Software Package
CTO says 10-person company is profitable and has customers in the pipeline to add to the likes of GSK and J.D. Edwards. 'It's easy to install and get up and running. We want to be the Google of approval management software,' Rick Trusky adds.
Amphora Names Channel Exec
E-mail Preferences
Japan's tech titans post record losses
FBI study reveals cyber crime trends
Community collaborates for Triangle Wiki
Video game conference is strictly…
Re-program speed dial before Saturday
Red Hat exec talks about company's $1B…
Bloomberg: Cisco sets sights on video…
Duke doc's group discovers cancer link
MedCity
- Hepatitis C, liver cancer research at UNC secures $2.3M federal grant
- Minimally invasive spinal product firm raises $25 million in Series C round
- HGSI thwarts GSK takeover with poison pill, buys time to seek other offers
- New partnership could boost CoverMyMeds’ health insurance customer base
- Data crunching diabetes: 8,000 zip codes identified for early intervention

![[VIDEO]](http://wwwcache.wral.com/asset/business/2012/05/11/11091792/11091793-1336751325-80x60.jpg)
![[VIDEO]](http://wwwcache.wral.com/asset/news/national_world/national/2011/09/29/10199582/craigslist-80x60.jpg)
![[VIDEO]](http://wwwcache.wral.com/asset/news/local/2012/04/30/11041295/11041296-1335823461-80x60.jpg)
![http://wwwcache.wral.com/asset/business/2012/04/26/11030087/BSH-80x60.jpg [VIDEO]](http://wwwcache.wral.com/presentation/v2/images/1x1.gif)